NEW YORK (TheStreet) -- CHANGE IN RATINGS
Aetna (AET) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $83. Company is keeping a tight lid on costs and should realize higher synergies from the CVH deal, Credit Suisse said.
(ALB) was upgraded at Bank of America/Merrill Lynch to buy from neutral. Twelve-month price target is $71. See improved growth in catalysts over the coming quarters, BofA/Merrill said.
Avery Dennison (AVY) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $57. Stock is trading at a discount to its peers and management should continue to execute, Robert Baird said.
American Axle & Manufacturing (AXL) was upgraded to buy at TheStreet Ratings.
CACI International (CACI) was upgraded at J.P. Morgan to overweight from neutral. Driven by relative value in SMID defense and an eventual shift back to the more typical pensions-adjusted EPS from GAAP as basis for valuing large-cap defense, J.P. Morgan said.Commerce Bancshares (CBSH) was upgraded at Bank of America/Merrill Lynch to neutral. Twelve-month price target is $46. Margin stabilization should support spread revenue growth, BofA/Merrill said.
CVS Caremark (CVS) was initiated with an outperform rating at Leerink Swann. Twelve-month price target is $85. Retail and mail PBM model should drive growth, Leerink Swann said. (CYN) was upgraded at Bank of America/Merrill Lynch to neutral from underperform. Twelve-month price target is $80. Company is leveraged to higher interest rates and can generate high growth, BofA/Merrill said. Dupont (DD) was upgraded at Bank of America/Merrill Lynch to buy from neutral. Twelve-month price target is $70. Company is inexpensive and has leverage to growing demand for specialty chemicals, BofA/Merrill said.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts